3SBio, Inc. (TRSBF)
2.20
+0.20
(+10.00%)
USD |
OTCM |
Jun 10, 16:00
3SBio Market Cap : 5.334B for June 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 10, 2026 | 5.334B |
| June 09, 2026 | 4.849B |
| June 08, 2026 | 4.849B |
| June 05, 2026 | 6.061B |
| June 04, 2026 | 6.061B |
| June 03, 2026 | 6.061B |
| June 02, 2026 | 6.061B |
| June 01, 2026 | 6.061B |
| May 29, 2026 | 6.182B |
| May 28, 2026 | 6.182B |
| May 27, 2026 | 6.377B |
| May 26, 2026 | 6.377B |
| May 22, 2026 | 6.377B |
| May 21, 2026 | 6.377B |
| May 20, 2026 | 6.377B |
| May 19, 2026 | 6.377B |
| May 18, 2026 | 6.302B |
| May 15, 2026 | 7.127B |
| May 14, 2026 | 7.127B |
| May 13, 2026 | 7.127B |
| May 12, 2026 | 7.127B |
| May 11, 2026 | 7.127B |
| May 08, 2026 | 7.127B |
| May 07, 2026 | 6.877B |
| May 06, 2026 | 6.877B |
| Date | Value |
|---|---|
| May 05, 2026 | 6.877B |
| May 04, 2026 | 6.877B |
| May 01, 2026 | 7.064B |
| April 30, 2026 | 7.064B |
| April 29, 2026 | 7.064B |
| April 28, 2026 | 7.064B |
| April 27, 2026 | 7.064B |
| April 24, 2026 | 6.665B |
| April 23, 2026 | 6.665B |
| April 22, 2026 | 7.396B |
| April 21, 2026 | 7.078B |
| April 20, 2026 | 7.078B |
| April 17, 2026 | 7.078B |
| April 16, 2026 | 7.078B |
| April 15, 2026 | 7.078B |
| April 14, 2026 | 7.078B |
| April 13, 2026 | 7.078B |
| April 10, 2026 | 7.078B |
| April 09, 2026 | 7.078B |
| April 08, 2026 | 7.078B |
| April 07, 2026 | 7.078B |
| April 06, 2026 | 7.078B |
| April 02, 2026 | 7.078B |
| April 01, 2026 | 7.078B |
| March 31, 2026 | 6.158B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ascletis Pharma, Inc. | 1.513B |
| CStone Pharmaceuticals Co. Ltd. | 676.46M |
| RemeGen Co., Ltd. | 5.314B |
| InnoCare Pharma Ltd. | 2.731B |
| Adagene, Inc. | 125.59M |
Market Cap Related Metrics
| PE Ratio | 4.581 |
| PS Ratio | 2.190 |
| PEG Ratio | 0.0104 |
| Price to Book Value | 35.49 |
| Price to Free Cash Flow | 4.166 |
| Price | 2.20 |
| Earnings Yield | 21.83% |
| PEGY Ratio | 0.0103 |
| Operating PE Ratio | 3.662 |
| Normalized PE Ratio | 4.680 |